Mobia Medical, Inc MOBI
—
9.06
0.25
2.84%
as of 25 Sep
- Market cap
- $293.3M
- P/E
- 0.0×
Follow MOBI
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+2 more quarters Free account |
0.00 | — | 0.00 | 0.00 |
P/S ratio |
0.00 | — | 0.00 | 6.75 | |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | |
P/Operating CF |
(0.61) | — | (0.61) | (16.32) | |
P/B ratio |
0.00 | — | 0.00 | 1.48 | |
Price to Tangible BV |
0.00 | — | 0.00 | 1.48 | |
EV/Sales |
0.00 | — | 0.00 | 2.27 | |
EV/EBITDA |
0.00 | — | 0.00 | 0.00 | |
EV/Operating CF |
(0.04) | — | (0.04) | (0.95) | |
EV/FCF |
(0.04) | — | (0.04) | (0.93) | |
Quick Ratio |
— | 3.73 | 5.12 | 12.63 | |
Current Ratio |
— | 4.54 | 6.06 | 13.28 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.46 | 9.56 | |
Debt/Assets |
0.00% | 14.81% | 65.20% | 3.73% | |
Debt/Equity |
0.00 | 0.25 | 3.99 | 0.04 | |
Asset Turnover |
— | — | 0.00 | 0.39 | |
Operating CF/Net income |
1.05 | 0.00 | 1.00 | 0.74 | |
Capex/Depreciation |
0.00 | (1.94) | (0.23) | (9.81) | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
21.25% | — | 14.01% | 16.87% | |
Selling, General and Administrative Expense of Revenue |
217.74% | — | 208.60% | 199.08% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
6.05% | — | 3.37% | 11.90% | |
Graham Net Nets |
0.94 | — | 0.94 | 0.66 | |
Graham Number |
0.00 | — | 0.00 | 0.00 | |
Earnings Yield |
(341.88%) | — | (341.88%) | (341.88%) | |
Free Cash Flow Yield |
(783.22%) | — | (783.22%) | (35.98%) | |
Revenue per Share |
7.92 | — | 13.14 | 0.71 | |
Operating CF per Share |
(13.05) | 0.00 | (19.29) | (0.82) | |
Capex per Share |
0.00 | 0.00 | (0.05) | (0.08) | |
Free Cash Flow per Share |
(13.05) | 0.00 | (19.34) | (0.90) | |
Cash per Share |
0.00 | 0.00 | 60.64 | 9.28 | |
Shareholders Equity per Share |
0.00 | 0.00 | 13.08 | 9.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 13.08 | 9.04 | |
Free Cash Flow |
(11.00) | (46.06) | (17.77) | (17.21) | |
Working Capital |
— | 36.15 | 59.88 | 177.68 | |
Capital Expenditures |
0.00 | (0.36) | (0.04) | (1.54) | |
Net Current Asset Value |
0.00 | 27.21 | 10.14 | 169.47 | |
EV/EBIT |
0.00 | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.11 | |
Net Profit Margin |
(157.18%) | — | (146.93%) | (155.82%) | |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Assets |
— | — | 47.84 | 97.64 |
Columns are period end dates